olanzapine

Generic: olanzapine

Labeler: qilu pharmaceutical co., ltd.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name olanzapine
Generic Name olanzapine
Labeler qilu pharmaceutical co., ltd.
Dosage Form INJECTION, POWDER, FOR SOLUTION
Routes
INTRAMUSCULAR
Active Ingredients

olanzapine 10 mg/2mL

Manufacturer
Qilu Pharmaceutical Co., Ltd.

Identifiers & Regulatory

Product NDC 67184-0573
Product ID 67184-0573_816c3bbf-aa02-47e2-88d2-3a50c7764a84
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA218116
Listing Expiration 2026-12-31
Marketing Start 2025-11-11

Pharmacologic Class

Established (EPC)
atypical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 671840573
Hyphenated Format 67184-0573

Supplemental Identifiers

RxCUI
485968
UNII
N7U69T4SZR
NUI
N0000175430

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name olanzapine (source: ndc)
Generic Name olanzapine (source: ndc)
Application Number ANDA218116 (source: ndc)
Routes
INTRAMUSCULAR
source: ndc

Resolved Composition

Strengths
  • 10 mg/2mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (67184-0573-1) / 2 mL in 1 VIAL
source: ndc

Packages (1)

Ingredients (1)

olanzapine (10 mg/2mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR"], "spl_id": "816c3bbf-aa02-47e2-88d2-3a50c7764a84", "openfda": {"nui": ["N0000175430"], "unii": ["N7U69T4SZR"], "rxcui": ["485968"], "spl_set_id": ["12ce860a-6f22-4db6-8acf-786b40f5a5a5"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Qilu Pharmaceutical Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (67184-0573-1)  / 2 mL in 1 VIAL", "package_ndc": "67184-0573-1", "marketing_start_date": "20251111"}], "brand_name": "Olanzapine", "product_id": "67184-0573_816c3bbf-aa02-47e2-88d2-3a50c7764a84", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "67184-0573", "generic_name": "Olanzapine", "labeler_name": "Qilu Pharmaceutical Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Olanzapine", "active_ingredients": [{"name": "OLANZAPINE", "strength": "10 mg/2mL"}], "application_number": "ANDA218116", "marketing_category": "ANDA", "marketing_start_date": "20251111", "listing_expiration_date": "20261231"}